+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceuticals Market Outlook to 2027

  • PDF Icon


  • 80 Pages
  • July 2023
  • Region: Global
  • Ken Research Private Limited
  • ID: 5846606
The report provides a comprehensive analysis of the potential of Global Biopharmaceuticals. The report covers an overview and genesis of the industry, market size in terms of revenue generated.

The report has market segmentation which includes segments By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing/Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP/EP/JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other). The report includes Porter’s five force analysis, growth enablers, recent trends & developments, pain points & solutions. The report concludes with future market projections of each market segmentation and analyst recommendations.

Market Overview

According to publisher estimates, the Global Biopharmaceuticals Market which grew at a robust CAGR from 2017-2022 & is forecasted to grow steadily from 2022-2027 driven by increase in chronic illness cases, innovative technologies alongside growing inorganic growth strategies.
  • Governments across the world are implementing supportive regulations and policies to encourage the development and commercialization of biopharmaceutical products
  • The biopharmaceutical industry is witnessing rapid technological advancements, including the development of novel drug delivery systems, gene therapies, and personalized medicine. These advancements are driving innovation and improving the efficacy and safety of biopharmaceutical products

Key Trends by Market Segment:

  • By Product: Monoclonal antibodies are estimated to hold the largest market share owing to the exponential research and applications within the oncology department
  • By Service: On the basis of service, the biopharmaceuticals market is segmented into laboratory testing, custom testing/customer proprietary testing, compendial and multi compendial laboratory testing. Laboratory Testing is expected to capture the largest share of market

Competitive Landscape

The Global Biopharmaceuticals market is moderately fragmented with players occupying almost half of the market. The key players operating in the market are not only competing based on product quality and promotion but are also focusing on strategic moves to hold larger market shares. The major companies dominating the Global Biopharmaceuticals market for its products, services, and continuous product developments are the basis of flexibility and price, brand recognition, quality, and the overall variety of the product offering among others.

Future Outlook

The Global Biopharmaceuticals Market witnessed significant growth during the period 2017-2022, owing to increase in chronic illness cases, enhancing service offerings alongside increase in product innovativeness.

Growth rate of the market is going to increase over the period as market penetration rates increase.
This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.

Table of Contents

1. Executive Summary
1.1 How is Biopharmaceuticals Market Positioned Globally?
2. Global Biopharmaceuticals Overview
2.1 Global Biopharmaceuticals Overview
2.2 Ecosystem of Global Biopharmaceuticals Market
2.3 Business Cycle of Global Biopharmaceuticals
2.4 Business Model in Global Biopharmaceuticals
2.5 Timeline of Major Players Global Biopharmaceuticals
2.6 Recent collaborations in Global Biopharmaceuticals
3. Global Biopharmaceuticals Segmentation, 2022
3.1 Global Biopharmaceuticals Size, 2017-2022
3.2 Global Biopharmaceuticals Segmentation based on the type of Product, 2022
3.3 Global Biopharmaceuticals Segmentation based on the type of Geography, 2022
3.4 Global Biopharmaceuticals Segmentation based on the type of Application, 2022
4. End User Analysis of Global Biopharmaceuticals
4.1 End-to-end process in Global Biopharmaceuticals
4.2 Decision Making Parameters for farmers in Global Biopharmaceuticals
5. Industry Analysis of Global Biopharmaceuticals
5.1 Porter’s Five Forces Analysis on Global Biopharmaceuticals
5.3 Growth Enablers in Global Biopharmaceuticals
5.4 Bottlenecks and Challenges in the Global Biopharmaceuticals
5.5 Trends and Developments in Global Biopharmaceuticals
5.6 SWOT Analysis of Global Biopharmaceuticals
5.7 Overview of how the COVID-19 Pandemic impacted the Global Biopharmaceuticals Market
6. Competition Framework for Global Biopharmaceuticals
6.1 Competitive Landscape in Global Biopharmaceuticals
6.2 Market shares for Major Players present in Global Biopharmaceuticals
6.3 Cross Comparison of Major Players in Global Biopharmaceuticals
6.4 Business Strategies of Major Players in Global Biopharmaceuticals Market
7. Future Outlook and Projections of the Market, 2022-2027
7.1 Global Biopharmaceuticals Size Future Outlook, 2022-2027
7.2 Global Biopharmaceuticals Segmentation based on the type of product, 2027
7.3 Global Biopharmaceuticals Segmentation based on the type of geography, 2027
7.4 Upcoming Technologies in Global Biopharmaceuticals
8. Market Opportunity and Analyst Recommendations
8.1 Recommendation for Global Biopharmaceuticals Players- Operational Strategies
8.2 Recommendation for Global Biopharmaceuticals Players- Marketing Strategies
9. Research Methodology
9.1 Market Definitions
9.2 Abbreviations Used
9.3 Market Sizing Approach
9.4 Consolidated Research Approach
9.5 Understanding Market Potential through In-Depth Industry Interviews
9.6 Research Limitations
9.7 Future Conclusion
  • Disclaimer
  • Contact the Publisher

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Johnson & Johnson
  • Pfizer
  • Novartis
  • Merck & Co
  • Amgen
  • Bayer
  • Roche
  • Cipla